Also Read | A year on, China is shaking up the worldSerum Institute of India’s Covishield vaccine-Covishield has been developed by Oxford University in collaboration with Astrazeneca.
Serum Institute of India is their manufacturing and trial partner.-Covishield uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein.-The Subject Expert Committee (SEC) has recommended the approval of two full doses of the vaccine administered around 4-6 weeks apart.